Pinetree Therapeutics Secures $47 Million to Propel Innovative Oncology Drug Development Pinetree Therapeutics has successfully closed a $47 million Series B funding round, aimed at advancing its innovative oncology programs and enhancing its protein degradation technology.

Pinetree Therapeutics Secures $47 Million to Propel Innovative Oncology Drug Development #United_States #Cambridge #Series_B_Funding #Pinetree_Therapeutics #Oncological_Research